melatonin and levodopa

melatonin has been researched along with levodopa in 45 studies

Research

Studies (45)

TimeframeStudies, this research(%)All Research%
pre-199010 (22.22)18.7374
1990's10 (22.22)18.2507
2000's14 (31.11)29.6817
2010's10 (22.22)24.3611
2020's1 (2.22)2.80

Authors

AuthorsStudies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Audibert, B; Perrottet, E1
Allen, JP; Bell, R; Jordan, RM; McDonald, SD; Stevens, EA; Vaughan, GM1
Arendt, J1
Moore, DC; Paunier, L; Sizonenko, PC1
Sandyk, R1
Anninos, PA; Derpapas, K; Sandyk, R; Tsagas, N1
Deng, MH; Lopez G-Coviella, I; Lynch, HJ; Wurtman, RJ1
Auff, E; Doppelbauer, A; Fertl, E; Waldhauser, F2
Abreu, P; Alonso, R; Calzadilla, CH; Hernandez, G; Santana, C1
Mitsuma, T; Nogimori, T1
Hadjiconstantinou, M; Neff, NH1
Linkowski, P; Mendlewicz, J1
Burg, AC; Horowitz, ZD; Weinberg, U; Weitzman, ED1
Anisimov, VN1
Krieger, M; Nguyen-Legros, J; Simon, A1
Alexiuk, NA; Vriend, JP1
Alexiuk, NA; Uddin, M; Vriend, J1
Joseph, JA; Miller, JW; Selhub, J1
Bieglmayer, C; Birnbacher, R; Blau, N; Frisch, H; Scheibenreiter, S; Waldhauser, F1
Doroshenko, EM; Etingof, RN; Lavrikova, EV; Pozdeyev, NV1
Abreu, P; Gonzalez, MC; Sanchez, JJ1
Garcia-Borreguero, D; Granizo, JJ; Larrosa, O; Serrano, C1
Birman, S; Coulom, H1
Daya, S; Maharaj, H; Mokokong, R; Scheepers, M; Sukhdev Maharaj, D1
Willis, GL1
Desole, MS; Esposito, G; Marchetti, B; Miele, E; Migheli, R; Rocchitta, G; Serra, PA1
Abreu-González, P; Afonso-Oramas, D; Barroso-Chinea, P; Cruz-Muros, I; González, MC; González-Hernández, T1
Alexiuk, NA; Vriend, J1
Fertl, E1
Chaturvedi, CM; Kumar, P; Mohan, J; Pati, AK; Sastry, KV; Tyagi, JS1
Chaturvedi, CM; Kumar, P1
Borah, A; Mohanakumar, KP1
Arnulf, I; Boniol, C; Clot, F; Decaix, C; Leu-Semenescu, S; Levy, R; Moussa, F; Roze, E; Touitou, Y; Vidailhet, M1
Chakraborty, J; Dhanasekaran, M; Manivasagam, T; Mohanakumar, KP; Naskar, A; Singh, R; Thomas, B1
Farag, NE; Hammad, LN; Zaitone, SA1
Bolitho, SJ; Grunstein, RR; Hodges, JR; Lewis, SJ; Naismith, SL; Rajaratnam, SM; Rogers, N; Terpening, Z1
Dutta, D; Mohanakumar, KP; Naskar, A; Prabhakar, V; Singh, R1
Adrien, J; Belaid, H; François, C; Hirsch, EC; Karachi, C1
Coleman-Jackson, R; Hershey, LA1
Kataoka, H; Kurumatani, N; Obayashi, K; Saeki, K; Sugie, K1

Reviews

4 review(s) available for melatonin and levodopa

ArticleYear
Catecholamine systems of retina: a model for studying synaptic mechanisms.
    Life sciences, 1984, Sep-10, Volume: 35, Issue:11

    Topics: Adenylyl Cyclases; Adrenergic alpha-Agonists; Animals; Antipsychotic Agents; Darkness; Dopamine; Electrophysiology; Enzyme Activation; Epinephrine; Evoked Potentials, Visual; gamma-Aminobutyric Acid; Humans; Levodopa; Light; Melatonin; Narcotics; Neurons; Norepinephrine; Parkinson Disease; Receptors, Adrenergic; Retina; Schizophrenia; Serotonin

1984
[Neuroendocrinology of depressive disorders].
    La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1982, Dec-02, Volume: 58, Issue:44

    Topics: Adrenocorticotropic Hormone; Depressive Disorder; Dexamethasone; Dextroamphetamine; Growth Hormone; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Levodopa; Melatonin; Periodicity; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone

1982
The role of ML-23 and other melatonin analogues in the treatment and management of Parkinson's disease.
    Drug news & perspectives, 2005, Volume: 18, Issue:7

    Topics: 5-Methoxytryptamine; Animals; Antiparkinson Agents; Disease Models, Animal; Humans; Levodopa; Melatonin; Parkinson Disease

2005
Pharmacological Management of Dementia with Lewy Bodies.
    Drugs & aging, 2019, Volume: 36, Issue:4

    Topics: Age Factors; Aged; Anticonvulsants; Antiparkinson Agents; Cholinesterase Inhibitors; Clinical Trials, Phase II as Topic; Clonazepam; Humans; Levodopa; Lewy Body Disease; Melatonin; Randomized Controlled Trials as Topic; Zonisamide

2019

Trials

3 trial(s) available for melatonin and levodopa

ArticleYear
Circadian secretion pattern of melatonin in Parkinson's disease.
    Journal of neural transmission. Parkinson's disease and dementia section, 1991, Volume: 3, Issue:1

    Topics: Adult; Aged; Biomarkers; Circadian Rhythm; Female; Humans; Levodopa; Male; Melatonin; Middle Aged; Parkinson Disease

1991
Lack of an effect of melatonin on the basal and L-dopa stimulated growth hormone secretion in men.
    Journal of neural transmission, 1981, Volume: 52, Issue:1-2

    Topics: Adult; Growth Hormone; Humans; Kinetics; Levodopa; Male; Melatonin

1981
Circadian effects of dopaminergic treatment in restless legs syndrome.
    Sleep medicine, 2004, Volume: 5, Issue:4

    Topics: Adult; Circadian Rhythm; Dopamine Agents; Female; Humans; Levodopa; Lighting; Male; Melatonin; Middle Aged; Polysomnography; Restless Legs Syndrome; Saliva; Time Factors

2004

Other Studies

38 other study(ies) available for melatonin and levodopa

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
[Hypothalamic hormones and the central nervous system].
    Annales medico-psychologiques, 1975, Volume: 1, Issue:4

    Topics: Catecholamines; Central Nervous System; Corticotropin-Releasing Hormone; Cyclic AMP; Gonadotropin-Releasing Hormone; Growth Hormone-Releasing Hormone; Humans; Hypothalamus; Levodopa; Lithium; Melatonin; MSH Release-Inhibiting Hormone; Pituitary Hormone Release Inhibiting Hormones; Pituitary Hormone-Releasing Hormones; Prolactin Release-Inhibiting Factors; Psychotropic Drugs; Serotonin; Somatostatin; Thyrotropin-Releasing Hormone

1975
Melatonin, pituitary function and stress in humans.
    Psychoneuroendocrinology, 1979, Volume: 4, Issue:4

    Topics: Adrenocorticotropic Hormone; Adult; Circadian Rhythm; Endocrine System Diseases; Female; Follicle Stimulating Hormone; Growth Hormone; Humans; Hydrocortisone; Levodopa; Luteinizing Hormone; Male; Melatonin; Physical Exertion; Pituitary Gland; Stress, Physiological; Thyrotropin

1979
Melatonin assays in body fluids.
    Journal of neural transmission. Supplementum, 1978, Issue:13

    Topics: Acetyltransferases; Animals; Body Fluids; Circadian Rhythm; Female; Humans; Levodopa; Light; Male; Melatonin; Menstruation; Radioimmunoassay; Rats; Seasons

1978
Effect of adrenergic stimulation and blockade on melatonin secretion in the human.
    Progress in brain research, 1979, Volume: 52

    Topics: Adult; Circadian Rhythm; Humans; Levodopa; Male; Melatonin; Metaproterenol; Pineal Gland; Propranolol; Seasons

1979
Accelerated growth of malignant melanoma by levodopa in Parkinson's disease and role of the pineal gland.
    The International journal of neuroscience, 1992, Volume: 63, Issue:1-2

    Topics: Combined Modality Therapy; Corpus Striatum; Dyskinesia, Drug-Induced; Electric Stimulation; Equipment Design; Humans; Levodopa; Magnetics; Male; Melatonin; Middle Aged; Parkinson Disease; Pineal Gland

1992
Magnetic fields in the treatment of Parkinson's disease.
    The International journal of neuroscience, 1992, Volume: 63, Issue:1-2

    Topics: Combined Modality Therapy; Corpus Striatum; Dyskinesia, Drug-Induced; Electric Stimulation; Equipment Design; Humans; Levodopa; Magnetics; Male; Melatonin; Middle Aged; Parkinson Disease; Pineal Gland

1992
Melatonin and its precursors in Y79 human retinoblastoma cells: effect of sodium butyrate.
    Brain research, 1991, Oct-11, Volume: 561, Issue:2

    Topics: 5-Hydroxytryptophan; Analysis of Variance; Butyrates; Butyric Acid; Cell Line; Colforsin; Dopamine; Eye Neoplasms; Humans; Kinetics; Levodopa; Melatonin; Retinoblastoma; Serotonin; Spiperone

1991
Day-night rhythm of rat pineal tyrosine hydroxylase activity as determined by HPLC with amperometric detection.
    Journal of neurochemistry, 1987, Volume: 48, Issue:3

    Topics: Animals; Chromatography, High Pressure Liquid; Circadian Rhythm; Kinetics; Levodopa; Male; Melatonin; Pineal Gland; Rats; Rats, Inbred Strains; Tyrosine 3-Monooxygenase

1987
Effects of various drugs on thyrotropin secretion in rats.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1985, Volume: 17, Issue:7

    Topics: 5-Hydroxytryptophan; Animals; Dose-Response Relationship, Drug; Endorphins; Fenclonine; Haloperidol; Hypothalamus; Levodopa; Male; Melatonin; Phenytoin; Protein Precursors; Rats; Rats, Inbred Strains; Thyrotropin; Thyrotropin-Releasing Hormone; Time Factors

1985
Study on serotoninergic mechanisms of compensatory ovarian hypertrophy in rats.
    Endokrinologie, 1980, Volume: 75, Issue:2

    Topics: Animals; Brain; Castration; Diethylstilbestrol; Female; Hypertrophy; Indoles; Levodopa; Melatonin; Morpholines; Ovary; Pineal Gland; Pyridazines; Rats; Serotonin; Tryptophan

1980
Immunohistochemical localization of L-dopa and aromatic L-amino acid-decarboxylase in the rat retina.
    Investigative ophthalmology & visual science, 1994, Volume: 35, Issue:7

    Topics: Animals; Aromatic-L-Amino-Acid Decarboxylases; Dopamine; Fluorescent Antibody Technique; Immunoenzyme Techniques; Levodopa; Male; Melatonin; Rats; Rats, Wistar; Retina; Serotonin; Tyramine

1994
Melatonin reduces dopamine content in the neurointermediate lobe of male Syrian hamsters.
    Brain research bulletin, 1993, Volume: 32, Issue:4

    Topics: Analysis of Variance; Animals; Cricetinae; Dopamine; Levodopa; Male; Melatonin; Mesocricetus; Norepinephrine; Organ Size; Pituitary Gland, Posterior; Testis; Time Factors

1993
Circadian secretion pattern of melatonin in de novo parkinsonian patients: evidence for phase-shifting properties of l-dopa.
    Journal of neural transmission. Parkinson's disease and dementia section, 1993, Volume: 5, Issue:3

    Topics: Aged; Circadian Rhythm; Female; Humans; Levodopa; Male; Melatonin; Middle Aged; Movement Disorders; Muscle Rigidity; Parkinson Disease; Radioimmunoassay; Tremor

1993
Melatonin increases the in situ activity of tyrosine hydroxylase in the mediobasal hypothalamus of male Syrian hamsters.
    Life sciences, 1996, Volume: 59, Issue:8

    Topics: Animals; Arcuate Nucleus of Hypothalamus; Aromatic Amino Acid Decarboxylase Inhibitors; Cricetinae; Enzyme Inhibitors; Hydrazines; Hypothalamus, Middle; Levodopa; Male; Median Eminence; Melatonin; Mesocricetus; Reference Values; Time Factors; Tyrosine 3-Monooxygenase

1996
Oxidative damage caused by free radicals produced during catecholamine autoxidation: protective effects of O-methylation and melatonin.
    Free radical biology & medicine, 1996, Volume: 21, Issue:2

    Topics: Catecholamines; Copper Sulfate; Deoxyepinephrine; Dopamine; Free Radicals; Levodopa; Melatonin; Methylation; Oxidation-Reduction; Phycoerythrin; Spectrometry, Fluorescence; Tyrosine

1996
Hyperprolactinemia, a tool in treatment control of tetrahydrobiopterin deficiency: endocrine studies in an affected girl.
    Pediatric research, 1998, Volume: 43, Issue:4 Pt 1

    Topics: Adolescent; Biopterins; Carbidopa; Delayed-Action Preparations; Drug Combinations; Female; Follicle Stimulating Hormone; Human Growth Hormone; Humans; Hydrocortisone; Hyperprolactinemia; Insulin; Levodopa; Luteinizing Hormone; Melatonin; Phenylketonurias; Phosphorus-Oxygen Lyases; Prolactin

1998
The effects of melatonin and L-DOPA on the diurnal rhythms of free amino acids content in the rat retina.
    Journal of biological rhythms, 2000, Volume: 15, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Amino Acids; Animals; Chromatography, High Pressure Liquid; Circadian Rhythm; Dopamine; Dopamine Agents; Homovanillic Acid; Levodopa; Lighting; Male; Melatonin; Rats; Rats, Wistar; Retina

2000
Sodium nitroprusside stimulates L-DOPA release from striatal tissue through nitric oxide and cGMP.
    European journal of pharmacology, 2002, Mar-01, Volume: 438, Issue:1-2

    Topics: Animals; Corpus Striatum; Cyclic GMP; Dose-Response Relationship, Drug; Levodopa; Male; Melatonin; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Oxadiazoles; Quinoxalines; Rats; Rats, Sprague-Dawley; Salicylic Acid; Superoxide Dismutase; Uric Acid

2002
Chronic exposure to rotenone models sporadic Parkinson's disease in Drosophila melanogaster.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2004, Dec-01, Volume: 24, Issue:48

    Topics: Animals; Antioxidants; Apoptosis; Brain; Cell Count; Dopamine; Dopamine Agonists; Drosophila melanogaster; Electron Transport Complex I; Insecticides; Levodopa; Locomotion; Melatonin; Nerve Degeneration; Neurons; Oxidative Stress; Parkinsonian Disorders; Phenotype; Rotenone

2004
l-DOPA administration enhances 6-hydroxydopamine generation.
    Brain research, 2005, Nov-30, Volume: 1063, Issue:2

    Topics: Animals; Antioxidants; Antiparkinson Agents; Ascorbic Acid; Corpus Striatum; Drug Interactions; Edetic Acid; Hydroxylation; Iron; Levodopa; Lipid Peroxidation; Male; Melatonin; Oxidopamine; Rats; Rats, Wistar

2005
Endogenous melatonin protects L-DOPA from autoxidation in the striatal extracellular compartment of the freely moving rat: potential implication for long-term L-DOPA therapy in Parkinson's disease.
    Journal of pineal research, 2006, Volume: 40, Issue:3

    Topics: Animals; Ascorbic Acid; Corpus Striatum; Dopamine; Levodopa; Light; Male; Melatonin; Microdialysis; Movement; Oxidation-Reduction; Parkinson Disease; Quinones; Rats; Rats, Wistar

2006
Tetrahydrobiopterin stimulates L-DOPA release from striatal tissue.
    European journal of pharmacology, 2006, Jul-10, Volume: 541, Issue:1-2

    Topics: alpha-Methyltyrosine; Animals; Biopterins; Corpus Striatum; Dose-Response Relationship, Drug; Enzyme Inhibitors; Free Radical Scavengers; In Vitro Techniques; Levodopa; Male; Melatonin; NG-Nitroarginine Methyl Ester; Nitric Oxide Donors; Nitric Oxide Synthase; Nitroprusside; Pterins; Rats; Rats, Sprague-Dawley; Tyrosine 3-Monooxygenase

2006
Melatonin: effects on dopaminergic and serotonergic neurons of the caudate nucleus of the striatum of male Syrian hamsters.
    Journal of neural transmission (Vienna, Austria : 1996), 2007, Volume: 114, Issue:5

    Topics: 5-Hydroxytryptophan; Animals; Caudate Nucleus; Circadian Rhythm; Cricetinae; Dopamine; Enzyme Inhibitors; Levodopa; Male; Melatonin; Mesocricetus; Neural Pathways; Neurons; Serotonin; Sex Factors; Synaptic Transmission; Tryptophan Hydroxylase; Tyrosine 3-Monooxygenase

2007
Comment to the paper of Medeiros CAM, et al. (2007) J Neurol 254:459-464.
    Journal of neurology, 2008, Volume: 255, Issue:5

    Topics: Antiparkinson Agents; Central Nervous System Depressants; Circadian Rhythm; Drug Administration Schedule; Drug Interactions; Humans; Levodopa; Melatonin; Parkinson Disease; Placebo Effect; Randomized Controlled Trials as Topic; Sleep; Sleep Wake Disorders; Time Factors

2008
Effects of simulated hypo- and hyper-reproductive conditions on the characteristics of circadian rhythm in hypothalamic concentration of serotonin and dopamine and in plasma levels of thyroxine, triiodothyronine, and testosterone in Japanese quail, Coturn
    Chronobiology international, 2009, Volume: 26, Issue:1

    Topics: 5-Hydroxytryptophan; Animals; Circadian Rhythm; Coturnix; Dopamine; Hypothalamus; Levodopa; Male; Melatonin; Pineal Gland; Reproduction; Serotonin; Testosterone; Thyroxine; Triiodothyronine

2009
Reproductive responses and nitric oxide activity in Japanese quail, Coturnix coturnix japonica, are altered by specific phase relationships of neural (serotonergic and dopaminergic) oscillations and pineal function.
    Domestic animal endocrinology, 2009, Volume: 36, Issue:3

    Topics: 5-Hydroxytryptophan; Animals; Biological Clocks; Cloaca; Coturnix; Dopamine; Levodopa; Male; Melatonin; Neurons; Nitrates; Nitric Oxide; Nitrites; Organ Size; Pineal Gland; Random Allocation; Serotonin; Spermatogenesis; Testosterone

2009
Melatonin inhibits 6-hydroxydopamine production in the brain to protect against experimental parkinsonism in rodents.
    Journal of pineal research, 2009, Volume: 47, Issue:4

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Ascorbic Acid; Brain; Central Nervous System Depressants; Chromatography, High Pressure Liquid; Dopamine; Dopamine Agents; Ferrous Compounds; Levodopa; Male; Melatonin; Mice; Mice, Inbred BALB C; Oxidopamine; Parkinsonian Disorders

2009
Sleep and rhythm consequences of a genetically induced loss of serotonin.
    Sleep, 2010, Volume: 33, Issue:3

    Topics: 5-Hydroxytryptophan; Adult; Alcohol Oxidoreductases; Antidepressive Agents, Second-Generation; Consanguinity; Disorders of Excessive Somnolence; Dopamine; Dopamine Agents; Drug Therapy, Combination; Humans; Hydrocortisone; Hyperphagia; Levodopa; Male; Melatonin; Polysomnography; Serotonin; Sleep; Sleep Disorders, Circadian Rhythm

2010
Melatonin synergizes with low doses of L-DOPA to improve dendritic spine density in the mouse striatum in experimental Parkinsonism.
    Journal of pineal research, 2013, Volume: 55, Issue:3

    Topics: Animals; Antiparkinson Agents; Central Nervous System Depressants; Corpus Striatum; Dendrites; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Levodopa; Melatonin; Mice; Mice, Inbred BALB C; MPTP Poisoning; Parkinson Disease, Secondary

2013
Antioxidant potential of melatonin enhances the response to L-dopa in 1-methyl 4-phenyl 1,2,3,6-tetrahydropyridine-parkinsonian mice.
    Pharmacological reports : PR, 2013, Volume: 65, Issue:5

    Topics: Animals; Antioxidants; Antiparkinson Agents; Basal Ganglia; Behavior, Animal; Carbidopa; Catalase; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Glutathione; Glutathione Peroxidase; Levodopa; Lipid Peroxidation; Male; Malondialdehyde; Melatonin; Mice; Motor Activity; Oxidative Stress; Parkinsonian Disorders; Superoxide Dismutase

2013
Disturbances in melatonin secretion and circadian sleep-wake regulation in Parkinson disease.
    Sleep medicine, 2014, Volume: 15, Issue:3

    Topics: Actigraphy; Antiparkinson Agents; Case-Control Studies; Chronobiology Disorders; Female; Humans; Levodopa; Male; Melatonin; Middle Aged; Parkinson Disease; Polysomnography; Saliva

2014
Melatonin enhances L-DOPA therapeutic effects, helps to reduce its dose, and protects dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.
    Journal of pineal research, 2015, Volume: 58, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Dopaminergic Neurons; Drug Synergism; Levodopa; Male; Melatonin; Mice; Mice, Inbred BALB C; Neuroprotective Agents; Parkinsonian Disorders; Substantia Nigra

2015
Effect of melatonin on sleep disorders in a monkey model of Parkinson's disease.
    Sleep medicine, 2015, Volume: 16, Issue:10

    Topics: Animals; Antiparkinson Agents; Central Nervous System Depressants; Disease Models, Animal; Levodopa; Macaca fascicularis; Male; Melatonin; Parkinson Disease; Sleep Wake Disorders

2015
Melatonin secretion in patients with Parkinson's disease receiving different-dose levodopa therapy.
    Sleep medicine, 2020, Volume: 75

    Topics: Aged; Antiparkinson Agents; Circadian Rhythm; Cross-Sectional Studies; Humans; Levodopa; Melatonin; Parkinson Disease

2020